PharmiWeb

Kallyope’s Phase 2b Study of Elismetrep, A Novel Approach for Treating Migraine, Presented at the American Academy of Neurology Annual Meeting

Data validate the efficacy, safety, and tolerability of elismetrep, an investigational first-in-class TRPM8 ...